Zi-Fan Yu, Sc.D., joined Statistics Collaborative, Inc. (SCI) in 2003. She is a member of the American Statistical Association, the International Biometric Society (Eastern North American Region), and the Society for Clinical Trials.
At SCI, Dr. Yu has been involved with clinical trials in cancer, cardiovascular disease, inborn errors of metabolism, and malaria. The interventions have been drugs, devices, vaccines, and replacement enzymes. She coordinated the statistical aspects of a clinical study report (CSR) and a premarket approval (PMA) application. Her other contributions have included project management, experimental design, protocol development, statistical analysis plans and analyses, and development of randomization schedules.
She received her B.A. in Mathematics and Philosophy from the University of Pennsylvania (1994) and her Sc.D. in Biostatistics from Harvard University (2002). Her dissertation was titled “Regression Methods for Quantitative Risk Assessment of Continuous Outcomes in Toxicology”.